Wall Street is mainly focused on Apple's iPhone sales in China and any guidance related to its March quarter, which could ...

Apple shares edged lower in early Thursday trading, extending a move into correction territory for the world's second-largest ...

But even as the tide sharply turns against DEI, not everyone is abandoning ship. Many major companies have made public ...

The six-year-long Apple Card partnership between Goldman Sachs and Apple might end sooner than expected. Here's who could ...

Apple partnered with Goldman Sachs for the card, which is optimized for ‌Apple Pay‌ but will still works like a traditional credit card for all of your transactions. There's a lot of fine ...

Goldman Sachs is telling investors to take a breath. Peter Oppenheimer, the bank’s chief global equity strategist, has told investors today that markets aren’t crashing—just cooling. “In our view, ...

Apple is in talks with Barclays to replace Goldman Sachs as the tech giant's credit card partner, said two sources familiar ...

Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...

Usually, if Apple is buying something from you, it’s a relatively good relationship (as long as you don’t mess anything up).

Goldman Sachs is making losses due to the Apple Card. But the US bank cannot get out of the contract. But CEO Solomon is not ...

Goldman Sachs is seeking to end its Apple Card partnership with Apply before their contract expires. “We have a contract with Apple to run that partnership until 2030, although there’s some ...

Apple shares edged higher in early Thursday trading, paring a move into correction territory for the world's second-largest tech stock, after Goldman Sachs analysts issued a price-target downgrade ...